This reprint focuses on the epidemiology of comorbidities, cardiovascular events, mineral bone disorders, and other complications in patients with chronic kidney disease. Significant topics addressed include women's health in CKD management, prognostic markers, therapy management, and mechanisms shared by the kidneys and other organs and/or diseases. The rationale and protocol of a new study on the use of Etelcalcetide for preserving vitamin K-dependent protein activity are also described.